BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hillenbrand A, Fassler J, Huber N, Xu P, Henne-Bruns D, Templin M, Schrezenmeier H, Wolf AM, Knippschild U. Changed adipocytokine concentrations in colorectal tumor patients and morbidly obese patients compared to healthy controls. BMC Cancer. 2012;12:545. [PMID: 23173608 DOI: 10.1186/1471-2407-12-545] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Amor S, Iglesias-de la Cruz MC, Ferrero E, García-Villar O, Barrios V, Fernandez N, Monge L, García-Villalón AL, Granado M. Peritumoral adipose tissue as a source of inflammatory and angiogenic factors in colorectal cancer. Int J Colorectal Dis 2016;31:365-75. [PMID: 26493186 DOI: 10.1007/s00384-015-2420-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
2 Chapkin RS, DeClercq V, Kim E, Fuentes NR, Fan YY. Mechanisms by Which Pleiotropic Amphiphilic n-3 PUFA Reduce Colon Cancer Risk. Curr Colorectal Cancer Rep 2014;10:442-52. [PMID: 25400530 DOI: 10.1007/s11888-014-0241-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
3 Liu F, Jiao Y, Jiao Y, Garcia-Godoy F, Gu W, Liu Q. Sex difference in EGFR pathways in mouse kidney-potential impact on the immune system. BMC Genet 2016;17:146. [PMID: 27881077 DOI: 10.1186/s12863-016-0449-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
4 Nielsen VG, Matika RW, Ley ML, Waer AL, Gharagozloo F, Kim S, Nfonsam VN, Ong ES, Jie T, Warneke JA, Steinbrenner EB. Tissue-type plasminogen activator-induced fibrinolysis is enhanced in patients with breast, lung, pancreas and colon cancer. Blood Coagul Fibrinolysis 2014;25:248-53. [PMID: 24674880 DOI: 10.1097/MBC.0000000000000040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
5 Catalán V, Gómez-Ambrosi J, Rodríguez A, Ramírez B, Ortega VA, Hernández-Lizoain JL, Baixauli J, Becerril S, Rotellar F, Valentí V, Moncada R, Silva C, Salvador J, Frühbeck G. IL-32α-induced inflammation constitutes a link between obesity and colon cancer. Oncoimmunology 2017;6:e1328338. [PMID: 28811968 DOI: 10.1080/2162402X.2017.1328338] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
6 Pérez-Hernández AI, Catalán V, Gómez-Ambrosi J, Rodríguez A, Frühbeck G. Mechanisms linking excess adiposity and carcinogenesis promotion. Front Endocrinol (Lausanne) 2014;5:65. [PMID: 24829560 DOI: 10.3389/fendo.2014.00065] [Cited by in Crossref: 20] [Cited by in F6Publishing: 47] [Article Influence: 2.5] [Reference Citation Analysis]
7 Hillenbrand A, Xu P, Zhou S, Blatz A, Weiss M, Hafner S, Henne-Bruns D, Knippschild U. Circulating adipokine levels and prognostic value in septic patients. J Inflamm (Lond) 2016;13:30. [PMID: 27601939 DOI: 10.1186/s12950-016-0138-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
8 Cheng KJ, Mejia Mohammed EH, Khong TL, Mohd Zain S, Thavagnanam S, Ibrahim ZA. IL-1α and colorectal cancer pathogenesis: Enthralling candidate for anti-cancer therapy. Crit Rev Oncol Hematol 2021;163:103398. [PMID: 34147647 DOI: 10.1016/j.critrevonc.2021.103398] [Reference Citation Analysis]
9 Olsen RS, Nijm J, Andersson RE, Dimberg J, Wågsäter D. Circulating inflammatory factors associated with worse long-term prognosis in colorectal cancer. World J Gastroenterol 2017; 23(34): 6212-6219 [PMID: 28974887 DOI: 10.3748/wjg.v23.i34.6212] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
10 Lu W, Huang Z, Li N, Liu H. Low circulating total adiponectin, especially its non-high-molecular weight fraction, represents a promising risk factor for colorectal cancer: a meta-analysis. Onco Targets Ther 2018;11:2519-31. [PMID: 29765231 DOI: 10.2147/OTT.S157255] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
11 Tilg H, Moschen AR. Mechanisms behind the link between obesity and gastrointestinal cancers. Best Pract Res Clin Gastroenterol. 2014;28:599-610. [PMID: 25194178 DOI: 10.1016/j.bpg.2014.07.006] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 6.0] [Reference Citation Analysis]
12 Ahechu P, Zozaya G, Martí P, Hernández-Lizoáin JL, Baixauli J, Unamuno X, Frühbeck G, Catalán V. NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development. Front Immunol 2018;9:2918. [PMID: 30619282 DOI: 10.3389/fimmu.2018.02918] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
13 Yang G, Fan W, Luo B, Xu Z, Wang P, Tang S, Xu P, Yu M. Circulating Resistin Levels and Risk of Colorectal Cancer: A Meta-Analysis. Biomed Res Int 2016;2016:7367485. [PMID: 27642602 DOI: 10.1155/2016/7367485] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
14 Zhu H, Liu M, Zhang N, Pan H, Lin G, Li N, Wang L, Yang H, Yan K, Gong F. Circulating and Adipose Tissue mRNA Levels of Zinc-α2-Glycoprotein, Leptin, High-Molecular-Weight Adiponectin, and Tumor Necrosis Factor-Alpha in Colorectal Cancer Patients With or Without Obesity. Front Endocrinol (Lausanne) 2018;9:190. [PMID: 29755407 DOI: 10.3389/fendo.2018.00190] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
15 Guffey CR, Fan D, Singh UP, Murphy EA. Linking obesity to colorectal cancer: recent insights into plausible biological mechanisms. Curr Opin Clin Nutr Metab Care. 2013;16:595-600. [PMID: 23743611 DOI: 10.1097/mco.0b013e328362d10b] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
16 Silva A, Faria G, Araújo A, Monteiro MP. Impact of adiposity on staging and prognosis of colorectal cancer. Crit Rev Oncol Hematol 2020;145:102857. [PMID: 31881452 DOI: 10.1016/j.critrevonc.2019.102857] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
17 Laiyemo AO. The risk of colonic adenomas and colonic cancer in obesity. Best Pract Res Clin Gastroenterol 2014;28:655-63. [PMID: 25194182 DOI: 10.1016/j.bpg.2014.07.007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
18 Yunusova NV, Kondakova IV, Kolomiets LA, Afanas'ev SG, Kishkina AY, Spirina LV. The role of metabolic syndrome variant in the malignant tumors progression. Diabetes Metab Syndr 2018;12:807-12. [PMID: 29699953 DOI: 10.1016/j.dsx.2018.04.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
19 Dalamaga M. Resistin as a biomarker linking obesity and inflammation to cancer: potential clinical perspectives. Biomark Med 2014;8:107-18. [PMID: 24325232 DOI: 10.2217/bmm.13.99] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 5.0] [Reference Citation Analysis]
20 Florescu A, Branisteanu D, Bilha S, Scripcariu D, Florescu I, Scripcariu V, Dimofte G, Grigoras I. Leptin and adiponectin dynamics at patients with rectal neoplasm - Gender differences. PLoS One 2019;14:e0212471. [PMID: 31425509 DOI: 10.1371/journal.pone.0212471] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Liu L, Zhai Z, Wang D, Ding Y, Chen X, Wang Q, Shu Z, Wu M, Chen L, He X, Fan D, Pan F, Xing M. The association between IL-1 family gene polymorphisms and colorectal cancer: A meta-analysis. Gene 2021;769:145187. [PMID: 32998046 DOI: 10.1016/j.gene.2020.145187] [Reference Citation Analysis]